CFO
Crinetics Pharmaceuticals, Inc.
Equibles does not estimate personal net worth.
Toby Schilke is recorded as CFO at Crinetics Pharmaceuticals, Inc.. Toby Schilke has spoken on 4 earnings calls across 1 company, most recently for Crinetics Pharmaceuticals, Inc. on May 7, 2026. Crinetics Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector.
“Turning to slide 16, our financial results for the first quarter 2026 demonstrate a balance of disciplined execution and strategic investment as we advance the development of our pipeline and commercial launch of Pelsonify.”
“Turning to slide 14, our financial results for the fourth quarter 2025 reflect our continued disciplined execution and strategic investment in advancing our pipeline and commercialization of Pelsonify.”
“Turning to slide 20, our financial results for the third quarter of 2025 reflect our continued disciplined execution and strategic investment in advancing our pipeline and commercialization of Pelsonify.”
“Turning to slide 13, I'm pleased to review our financial results for the second quarter of 2025 were to reflect our continued disciplined execution and strategic investment in advancing our pipeline and commercial capabilities for the second quarter we recognized one million dollars in revenue from our licensing and…”
Crinetics Pharmaceuticals, Inc.
CFO
Source not stated
Crinetics Pharmaceuticals, Inc.
Biotechnology · Healthcare
CFO
Crinetics Pharmaceuticals, Inc. Q1 FY2026 Earnings Call
Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc. Q4 FY2025 Earnings Call
Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc. Q3 FY2025 Earnings Call
Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc. Q2 FY2025 Earnings Call
Crinetics Pharmaceuticals, Inc.
